Magnetic Resonance Imaging and Brain Histopathology in Neuropsychiatric Systemic Lupus Erythematosus

Seminars in Arthritis and Rheumatism

Volumn 40, Issue 1, 2010, Pages 32-52

  Sibbitt, Wilmer L ^a   Brooks, William M ^b   Kornfeld, Mario ^a   Hart, Blaine L ^c   Bankhurst, Arthur D ^a   Roldan, Carlos A ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b Hoglund Brain Imaging University of Kansas Health Sciences Center   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Autopsy; Magnetic resonance; MRI; Neuropsychiatric; NPSLE; SLE

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTOPSY; BRAIN ATROPHY; BRAIN CALCIFICATION; BRAIN CYST; BRAIN DAMAGE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN TISSUE; BRAIN VENTRICLE DILATATION; CELL HYPERPLASIA; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GLIA CELL; HISTOPATHOLOGY; HUMAN; LEUKOENCEPHALOPATHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; WHITE MATTER; AGED; BRAIN; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRAIN; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TIME FACTORS; YOUNG ADULT;

EID: 77955272376     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2009.08.005     Document Type: Article

References (69)

1. Hanly J.G., Urowitz M.B., Su L., Sanchez-Guerrero J., Bae S.C., Gordon C., et al. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheum 2008, 59:721-729. Systemic Lupus International Collaborating Clinics.
2. Hanly J.G. The neuropsychiatric SLE SLICC inception cohort study. Lupus 2008, 17:1059-1063.
3. McCune W.J., MacGuire A., Aisen A., Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1988, 31:159-166.
4. Brooks W.M., Sabet A., Sibbitt W.L., Barker P.B., van Zijl P.C.M., Duyn J.H., et al. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheum 1997, 24:2323-2329.
5. Sundgren P.C., Jennings J., Attwood J.T., Nan B., Gebarski S., McCune W.J., et al. MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus. Neuroradiology 2005, 47:576-585.
6. Friedman S.D., Stidley C., Brooks W.M., Hart B.L., Sibbitt W.L. Brain injury and neurometabolic abnormalities in systemic lupus erythematosus. Radiology 1998, 209. 79-8.
7. Sibbitt W.L., Haseler L., Griffey R.H., Hart B., Sibbitt R.R., Matwiyoff N. Analysis of cerebral structural changes in systemic lupus erythematosus by MR proton spectroscopy. Am J Neuroradiol 1994, 15:923-928.
8. Sibbitt W.L., Brooks W.M., Haseler L.J., Griffey R.H., Frank L.M., Hart B.L., et al. Spin-spin relaxation of brain tissues in systemic lupus erythematosus. Arthritis Rheum 1995, 38:810-818.
9. Sibbitt W.L., Haseler L.J., Griffey R.R., Friedman S.D., Brooks W.M. Neurometabolism of active neuropsychiatric lupus determined by proton MR spectroscopy. AJNR Am J Neuroradiol 1997, 18:1271-1277.
10. Sibbitt W.L., Sibbitt R.R., Brooks W.M. Neuroimaging in neuropsychiatric SLE. Arthritis Rheum 1999, 42:2026-2038.
11. Sabet A., Sibbitt W.L., Stidley C.A., Danska J., Brooks W.M. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke 1998, 29:2254-2260.
12. Ishikawa O., Ohnishi K., Miyachi Y., Ishizaka H. Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging. Relationship to anticardiolipin antibody. J Rheumatol 1994, 21:87-90.
13. Jarek M., West S.G., Baker M.R., Rak K.M. Magnetic resonance imaging in systemic lupus erythematotus patients without a history of neuropsychiatric lupus erythematosus. Arthritis Rheum 1994, 37:1609-1613.
14. Sibbitt W.L., Sibbitt R.R., Griffey R.H., Eckel C.G., Bankhurst A.D. Magnetic resonance and CT imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 1989, 48:1014-1022.
15. Brooks W.M., Jung R.E., Ford C.C., Greinel E.J., Sibbitt W.L., et al. Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus. J Rheum 1999, 26:81-85.
16. Kozora E., West S.G., Kotzin B.L., Julian L., Porter S., Bigler E. Magnetic resonance imaging abnormalities and cognitive defects in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1998, 41:41-47.
17. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. 1982 Revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
18. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725-1726.
19. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992, 35:630-640. Committee on Prognosis Studies in SLE.
20. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996, 39:363-369.
21. Sibbitt W.L., Schmidt P.J., Hart B.L., Brooks W.M. Fluid Attenuated Inversion Recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus. J Rheumatol 2003, 30:1983-1989.
22. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999, 42:599-608.
23. Walecki J., Sierakowski S., Lewszuk A., Sulik A., Tarasow E., Lebkowska U. MR in neurological syndromes of connective tissue diseases. Med Sci Monit 2002, 8. MT105-11.
24. Moritani T., Shrier D.A., Numaguchi Y., Takahashi C., Yano T., Nakai K., et al. Diffusion-weighted echo-planar MR imaging of CNS involvement in systemic lupus erythematosus. Acad Radiol 2001, 8:741-753.
25. Bosma G.P., Huizinga T.W., Mooijaart S.P., Van Buchem M.A. Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus. AJNR Am J Neuroradiol 2003, 24:850-854.
26. Funata N. Cerebral vascular changes in systemic lupus erythematosus. Bull Tokyo Med Dent Univ 1979, 26:91-112.
27. Ellison D., Gatter K., Heryet A., Esiri M. Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus. J Clin Pathol 1993, 46:37-40.
28. Shiozawa S., Kuroki Y., Kim M., Hirohata S., Ogino T. Interferon-alpha in lupus psychosis. Arthritis Rheum 1992, 35:417-422.
29. Johnson R., Richardson E.P. The neurological manifestations of systemic lupus erythematosus. A clinical-pathological study of 24 cases and review of the literature. Medicine 1968, 47:337-369.
30. Ellis S.G., Verity M.A. Central nervous systemic involvement in systemic lupus erythematosus: a review of neuropathological findings in 57 cases, 1955-1977. Semin Arthritis Rheum 1979, 8:212-221.
31. Hanly J.G., Walsh N., Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 1992, 19:732-741.
32. Devinsky O., Petito C.K., Alonso D.R. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 1988, 23:380-384.
33. Sakaki T., Morimoto T., Utsumi S. Cerebral transmural angiitis and ruptured cerebral aneurysms in patients with systemic lupus erythematosus. Neurochirurgia (Stuttg) 1990, 33:132-135.
34. Hammad A., Tsukada Y., Torre N. Cerebral occlusive vasculopathy in systemic lupus erythematosus and speculation on the part played by complement. Ann Rheumatic Dis 1992, 51:550-552.
35. Hopkins P., Belmont H.M., Buyon J., Philips M., Weissman G., Abramson S.B. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis. Arthritis Rheum 1988, 31:632-641.
36. Belmont H.M., Abramson S.B., Lie J.T. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interactions of inflammatory cells and activated endothelium. Arthritis Rheum 1996, 39:9-22.
37. Falk R.J., Dalmasso A.P., Kim Y., Lam S., Michael A. Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus. N Engl J Med 1985, 312:1594-1599.
38. Mitsias P., Levine S.R. Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology 1994, 44:385-393.
39. Hughson M.D., McCarty G.A., Sholer C.M., Brumback R.A. Thrombotic cerebral arteriopathy in patients with the antiphospholipid syndrome. Mod Pathol 1993, 6:644-653.
40. Levine S.R., Deegan M.J., Futrell N., Welch K.M. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990, 40:1181-1189.
41. Bruyn G.A. Controversies in lupus: nervous system involvement. Ann Rheum Dis 1995, 54:159-167.
42. Shintaku M., Matsumoto R. Disseminated perivenous necrotizing encephalomyelitis in systemic lupus erythematosus: report of an autopsy case. Acta Neuropathol (Berl) 1998, 95:313-317.
43. Roldan C.A., Gelgand E.A., Qualls C.R., Sibbitt W.L. Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus. Am J Cardiol 2005, 95:1441-1447.
44. Roldan C.A., Gelgand E.A., Qualls C.R., Sibbitt W.L. Valvular heart disease is associated with non-focal neuropsychiatric systemic lupus erythematosus. J Clin Rheumatol 2006, 12:3-10.
45. Roldan C.A., Gelgand E.A., Qualls C.R., Sibbitt W.L. Valvular heart disease by transthoracic echocardiography is associated with focal brain injury and central neuropsychiatric systemic lupus erythematosus. Cardiology 2007, 108:331-337.
46. Roldan C.A., Qualls C.R., Sopko K.S., Sibbitt W.L. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol 2008, 35:224-229.
47. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001, 7:1189-1193.
48. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994, 330:613-622.
49. Kowal C., DeGiorgio L.A., Nakaoka T., Hetherington H., Huerta P.T., Diamond B., et al. Cognition and immunity; antibody impairs memory. Immunity 2004, 21:179-188.
50. Emmer B.J., Steens S.C., Steup-Beekman G.M., van der Grond J., Admiraal-Behloul F., Olofsen H., et al. Detection of change in CNS involvement in neuropsychiatric SLE: a magnetization transfer study. J Magn Reson Imaging 2006, 24:812-816.
51. Steens S.C., Steup-Beekman G.M., Bosma G.P., Admiraal-Behloul F., Olofsen H., Doornbos J., et al. The effect of corticosteroid medication on quantitative MR parameters of the brain. AJNR Am J Neuroradiol 2005, 26:2475-2480.
52. Bosma G.P., Steens S.C., Petropoulos H., Admiraal-Behloul F., van den Haak A., Doornbos J., et al. Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2004, 50:3195-3202.
53. Steens S.C., Admiraal-Behloul F., Bosma G.P., Steup-Beekman G.M., Olofsen H., Le Cessie S., et al. Selective gray matter damage in neuropsychiatric lupus. Arthritis Rheum 2004, 50:2877-2881.
54. Steens S.C., Bosma G.P., Steup-Beekman G.M., le Cessie S., Huizinga T.W., van Buchem M.A. Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus. Arthritis Res Ther 2006, 8:R38.
55. Dehmeshki J., Van Buchem M.A., Bosma G.P., Huizinga T.W., Tofts P.S. Systemic lupus erythematosus: diagnostic application of magnetization transfer ratio histograms in patients with neuropsychiatric symptoms-initial results. Radiology 2002, 222:722-728.
56. Steens S.C., Bosma G.P., ten Cate R., Doornbos J., Kros J.M., Laan L.A., et al. A neuroimaging follow up study of a patient with juvenile central nervous system systemic lupus erythematosus. Ann Rheum Dis 2003, 62:583-586.
57. Sanna G., Piga M., Terryberry J.W., Peltz M.T., Giagheddu S., Satta L., et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 2000, 9:573-583.
58. Braffman B.H., Zimmerman R.A., Trojanowski J.Q., Gonatas N.K., Hickey W.F., Schlaepfer W.W. Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. AJR Am J Roentgenol 1988, 151:551-558.
59. Braffman B.H., Zimmerman R.A., Trojanowski J.Q., Gonatas N.K., Hickey W.F., Schlaepfer W.W. Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. AJR Am J Roentgenol 1988, 151:559-566.
60. Grossman R.I., Braffman B.H., Brorson J.R., Goldberg H.I., Silberberg D.H., Gonzalez-Scarano F. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology 1988, 169:117-122.
61. Man'kovskii N.B. Diencephalic pathology in the clinical picture of certain collagenoses in young and middle aged patients. Gerontol Clin 1969, 11:231-238.
62. Anderson J.R. Intracerebral calcification in a case of systemic lupus erythematosus with neurological manifestations. Neuropathol Appl Neurobiol 1981, 7:161-166.
63. Nagaoka S., Matsunaga K., Chiba J., Ishigatsubo Y., Tani K. Five cases of systemic lupus erythematosus with intracranial calcification. Rinsho Shinkeigaku 1982, 22:635-643.
64. Yokota S., Mori T., Kosuge K., Takahashi K., Nishiyama Y., Uechi M., et al. Basal ganglia calcification in two children with systemic lupus erythematosus and neuropsychiatric manifestations. Ryumachi 1985, 25:115-122.
65. Stuart B.M., Gregson N.A. Cerebral calcification in a patient with systemic lupus erythematosus and a monoclonal IgG reactive with glial fibrillary acidic protein. Br J Rheumatol 1998, 37:1355-1357.
66. Shimojima Y., Gono T., Hoshi K., Yamamoto K., Yoshida K., Matsuda M., Ikeda S. Neuropsychiatric systemic lupus erythematosus associated with anti-phospholipid syndrome, showing massive intracranial calcifications. No To Shinkei 2003, 55:885-888.
67. Cañas C.A., Tobón G.J. Multiple brain calcifications in a patient with systemic lupus erythematosus. Clin Rheumatol 2008, 27(Suppl 2):S63-S65.
68. Viswanathan A., Chabriat H. Cerebral microhemorrhage. Stroke 2006, 37:550-555.
69. Haacke E.M., Xu Y., Cheng Y.C., Reichenbach J.R. Susceptibility weighted imaging (SWI). Magn Reson Med 2004, 52:612-618.